Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.
Willis, J.R., Sapparapu, G., Murrell, S., Julien, J.P., Singh, V., King, H.G., Xia, Y., Pickens, J.A., LaBranche, C.C., Slaughter, J.C., Montefiori, D.C., Wilson, I.A., Meiler, J., Crowe, J.E.(2015) J Clin Invest 125: 2523-2531
- PubMed: 25985274 
- DOI: 10.1172/JCI80693
- Primary Citation of Related Structures:  
4YAQ - PubMed Abstract: 
Several HIV envelope-targeting (Env-targeting) antibodies with broad and potent neutralizing activity have been identified and shown to have unusual features. Of these, the PG9 antibody has a long heavy chain complementarity determining region 3 (HCDR3) and possesses unique structural elements that interact with protein and glycan features of the HIV Env glycoprotein ...